×
Akıncı, S., Çoner, A., Akbay, E., Adar, A., & Müderrisoğlu, I. H. (2022). In-Hospital Bleeding and Mortality in Acute Coronary Syndrome Patients Treated with Tirofiban and Potent P2Y12 Inhibitors. Turk Kardiyol Dern Ars, 50(5), 320-326. https://doi.org/10.5543/tkda.2022.21311.
Akıncı S, Çoner A, Akbay E, Adar A, Müderrisoğlu IH. In-Hospital Bleeding and Mortality in Acute Coronary Syndrome Patients Treated with Tirofiban and Potent P2Y12 Inhibitors. Turk Kardiyol Dern Ars. 2022 July;50(5):320-326. doi:10.5543/tkda.2022.21311.
Akıncı S, Çoner A, Akbay E, et al. In-Hospital Bleeding and Mortality in Acute Coronary Syndrome Patients Treated with Tirofiban and Potent P2Y12 Inhibitors. Turk Kardiyol Dern Ars. 2022;50(5):320-326. doi:10.5543/tkda.2022.21311.
Akıncı, Sinan et al. "In-Hospital Bleeding and Mortality in Acute Coronary Syndrome Patients Treated with Tirofiban and Potent P2Y12 Inhibitors." Turk Kardiyol Dern Ars vol. 50,5 (2022): 320-326. doi:10.5543/tkda.2022.21311.
Akıncı, Sinan, Ali Çoner, Ertan Akbay, Adem Adar and Ibrahim Haldun Müderrisoğlu "In-Hospital Bleeding and Mortality in Acute Coronary Syndrome Patients Treated with Tirofiban and Potent P2Y12 Inhibitors." Turk Kardiyol Dern Ars 50, no. 5 (2022): 320-326. https://doi.org/10.5543/tkda.2022.21311.
Copied!